Viewing Study NCT01836120


Ignite Creation Date: 2025-12-25 @ 4:28 AM
Ignite Modification Date: 2025-12-26 @ 3:31 AM
Study NCT ID: NCT01836120
Status: UNKNOWN
Last Update Posted: 2013-04-19
First Post: 2013-04-17
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of Raltitrexed Plus Docetaxel Versus Docetaxel as Second-line Chemotherapy in Subjects With Gastric Cancer
Sponsor: Hebei Tumor Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module